300238 冠昊生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.2186.165-48.5049.7336.464
总资产报酬率 ROA (%)3.9514.597-34.8026.5984.080
投入资产回报率 ROIC (%)4.3365.169-39.4197.5944.738

边际利润分析
销售毛利率 (%)78.63779.12676.24675.11472.528
营业利润率 (%)11.3248.409-77.40616.67910.290
息税前利润/营业总收入 (%)11.4999.263-76.08618.17412.508
净利润/营业总收入 (%)7.4285.214-86.84110.3769.465

收益指标分析
经营活动净收益/利润总额(%)90.041136.150-5.83481.74887.941
价值变动净收益/利润总额(%)2.571-11.3443.760-5.710-7.000
营业外收支净额/利润总额(%)-0.521-5.9190.1850.608-0.196

偿债能力分析
流动比率 (X)1.6651.5471.5821.6601.447
速动比率 (X)1.2071.1331.2551.1241.028
资产负债率 (%)35.49832.76435.70631.9070.368
带息债务/全部投入资本 (%)15.1677.29610.3719.53418.988
股东权益/带息债务 (%)528.4791,184.959783.020852.859393.881
股东权益/负债合计 (%)210.768234.149202.793223.610174.677
利息保障倍数 (X)49.3986.999-51.98313.0495.589

营运能力分析
应收账款周转天数 (天)60.60059.28485.24882.110102.811
存货周转天数 (天)333.711284.357406.164395.607339.183